U.S. Markets close in 1 hr 56 mins

Repros Therapeutics Inc. (RPRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.302-0.002 (-0.722%)
As of 1:38PM EDT. Market open.
People also watch
SNSSOPXATHLDCYCCOGXI
Full screen
Previous Close0.305
Open0.310
Bid0.303 x 200
Ask0.306 x 1000
Day's Range0.295 - 0.328
52 Week Range0.260 - 2.280
Volume558,399
Avg. Volume398,353
Market Cap11.37M
Beta-0.29
PE Ratio (TTM)-0.49
EPS (TTM)-0.62
Earnings DateNov 6, 2017 - Nov 10, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Trade prices are not sourced from all markets
  • Associated Presslast month

    Repros Therapeutics reports 2Q loss

    The The Woodlands, Texas-based company said it had a loss of 8 cents per share. The biopharmaceutical company posted revenue of $7,000 in the period. The company's shares closed at 35 cents. A year ago, ...

  • GlobeNewswirelast month

    Repros Therapeutics Inc.® Reports Second Quarter 2017 Financial Results

    THE WOODLANDS, Texas, Aug. 14, 2017-- Repros Therapeutics Inc. ® today announced financial results for the second quarter ended June 30, 2017.. Net loss for the three month period ended June 30, 2017, ...

  • Repros (RPRX) Q2 Earnings: What's in Store for the Stock?
    Zacks2 months ago

    Repros (RPRX) Q2 Earnings: What's in Store for the Stock?

    Lack of revenues in Repros Therapeutics' (RPRX) product portfolio could be a concern. But the company's most advanced pipeline candidates -- enclomiphene and Proellex -- might better its results in Q2.